Join
Live feed
·
PRReleasevia Quantisnow
BeOne Medicines Ltd. logo

BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA

ByQuantisnow·Wall Street's wire, on your screen.
ONC· BeOne Medicines Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONC (BeOne Medicines Ltd.) and more on Quantisnow.